Skip to main content
M

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Filings indexed 109 across all filing types
Latest filing 2026-04-16 Interim / Quarterly Rep…
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 1.3MB
Interim / Quarterly Report Classification · 1% confidence The document is a 'Quarterly Report' for the period ended 31 March 2026, issued by Memphasys Limited. It contains detailed financial highlights, operational updates, management commentary, and references to an 'Appendix 4C cashflow report'. It provides substantive financial and operational analysis rather than just an announcement of a report. Therefore, it is classified as an Interim/Quarterly Report. Q3 2026
2026-04-16 English
Investor Presentation - April 2026 20 pages 1.8MB
Regulatory Filings
2026-04-06 English
Memphasys Investor Webinar 2 pages 275.0KB
Regulatory Filings
2026-04-01 English
MENA Orders Secured, Expanded & Operations Unaffected 4 pages 352.5KB
Regulatory Filings
2026-03-19 English
Appendix 4D - Half-year Financial Report - 31 December 2025 21 pages 1.1MB
Regulatory Filings
2026-02-26 English
Change in substantial holding 2 pages 364.4KB
Regulatory Filings
2026-02-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.